Skip to main content
Top
Published in: Nutrition & Metabolism 1/2006

Open Access 01-12-2006 | Research

Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes

Authors: Yuchang Fu, Liehong Luo, Nanlan Luo, W Timothy Garvey

Published in: Nutrition & Metabolism | Issue 1/2006

Login to get access

Abstract

Resistin is secreted from adipocytes, and high circulating levels have been associated with obesity and insulin resistance. To investigate whether resistin could exert autocrine effects in adipocytes, we expressed resistin gene in 3T3-L1 fibroblasts using a lentiviral vector, and selected several stably-transduced cell lines under blasticidin selection.
We observed that 3T3-L1 adipocytes expressing resistin have a decreased gene expression for related transcriptional factors (CCAAT/enhancer binding protein α(C/EBPα) , peroxisome proliferator-activated receptor gamma (PPARγ), and adipocyte lipid binding protein (ALBP/aP2) which is one of target genes for the PPARγ during adipocyte differentiation,. Overexpression of resistin increased the levels of three proinflammatory cytokines, tumor necrosis factor alpha (TNFα), interleukin 6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1), which play important roles for insulin resistance, glucose and lipid metabolisms during adipogenesis. Furthermore, overexpressing resistin in adipocytes inhibits glucose transport 4 (GLUT4) activity and its gene expression, reducing insulin's ability for glucose uptake by 30 %.
In conclusion, resistin overexpression in stably transduced 3T3-L1 cells resulted in: 1) Attenuation of programmed gene expression responsible for adipogenesis; 2) Increase in expression of proinflammatory cytokines; 3) Decrease in insulin responsiveness of the glucose transport system. These data suggest a new role for resistin as an autocrine/paracrine factor affecting inflammation and insulin sensitivity in adipose tissue.
Appendix
Available only for authorised users
Literature
1.
go back to reference Havel P: Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Current Opinion in Lipidology. 2002, 13: 51-59. 10.1097/00041433-200202000-00008.CrossRef Havel P: Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Current Opinion in Lipidology. 2002, 13: 51-59. 10.1097/00041433-200202000-00008.CrossRef
2.
go back to reference Beltowski J: Adiponectin and resistin – new hormones of white adipose tissue. Med Sci Monit. 2003, 9: 55-61. Beltowski J: Adiponectin and resistin – new hormones of white adipose tissue. Med Sci Monit. 2003, 9: 55-61.
3.
go back to reference Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature. 2001, 409: 307-312. 10.1038/35053000.CrossRef Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature. 2001, 409: 307-312. 10.1038/35053000.CrossRef
4.
go back to reference Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA: A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA. 2001, 98: 502-506. 10.1073/pnas.98.2.502.CrossRef Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA: A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA. 2001, 98: 502-506. 10.1073/pnas.98.2.502.CrossRef
5.
go back to reference Kim KH, Lee K, Moon YS, Sul HS: A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 2001, 276: 11252-11256. 10.1074/jbc.C100028200.CrossRef Kim KH, Lee K, Moon YS, Sul HS: A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 2001, 276: 11252-11256. 10.1074/jbc.C100028200.CrossRef
6.
go back to reference Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, Sinha MK, Gingerich RL, Scherer PE, Ahima RS: Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes. 2004, 53: 1671-1679.CrossRef Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, Sinha MK, Gingerich RL, Scherer PE, Ahima RS: Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes. 2004, 53: 1671-1679.CrossRef
7.
go back to reference Rajala MW, Obici S, Scherer PE, Rossetti L: Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest. 2003, 111: 225-230. 10.1172/JCI200316521.CrossRef Rajala MW, Obici S, Scherer PE, Rossetti L: Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest. 2003, 111: 225-230. 10.1172/JCI200316521.CrossRef
8.
go back to reference Satoh H, Nguyen MTA, Miles PDG, Imamura T, Usui I, Olefsky JM: Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest. 2004, 114: 224-231. 10.1172/JCI200420785.CrossRef Satoh H, Nguyen MTA, Miles PDG, Imamura T, Usui I, Olefsky JM: Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest. 2004, 114: 224-231. 10.1172/JCI200420785.CrossRef
9.
go back to reference Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, Lazar MA: Regulation of fasted blood glucose by resistin. Science. 2004, 303: 1195-1198. 10.1126/science.1092341.CrossRef Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, Lazar MA: Regulation of fasted blood glucose by resistin. Science. 2004, 303: 1195-1198. 10.1126/science.1092341.CrossRef
10.
go back to reference Frost S, Lane M: Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J Biol Chem. 1985, 260: 2646-2652. Frost S, Lane M: Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J Biol Chem. 1985, 260: 2646-2652.
11.
go back to reference Mayor P, Maianu L, Garvey WT: Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes: Effects on glucose transporter gene expression. Diabetes. 1992, 41: 274-285.CrossRef Mayor P, Maianu L, Garvey WT: Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes: Effects on glucose transporter gene expression. Diabetes. 1992, 41: 274-285.CrossRef
12.
go back to reference Green H, Kehinde O: Sublines of mouse 3T3 cells that accumulate lipid. Cell. 1974, 1: 113-116. 10.1016/0092-8674(74)90126-3.CrossRef Green H, Kehinde O: Sublines of mouse 3T3 cells that accumulate lipid. Cell. 1974, 1: 113-116. 10.1016/0092-8674(74)90126-3.CrossRef
13.
go back to reference Green H, Kehinde O: An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell. 1975, 5: 19-27. 10.1016/0092-8674(75)90087-2.CrossRef Green H, Kehinde O: An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell. 1975, 5: 19-27. 10.1016/0092-8674(75)90087-2.CrossRef
14.
go back to reference Green H, Kehinde O: Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell. 1976, 7: 105-113. 10.1016/0092-8674(76)90260-9.CrossRef Green H, Kehinde O: Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell. 1976, 7: 105-113. 10.1016/0092-8674(76)90260-9.CrossRef
15.
go back to reference Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM: Transcriptional regulation of adipogenesis. Genes Dev. 2000, 14: 1293-1470. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM: Transcriptional regulation of adipogenesis. Genes Dev. 2000, 14: 1293-1470.
16.
go back to reference Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM: mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 1994, 8: 1224-1234.CrossRef Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM: mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 1994, 8: 1224-1234.CrossRef
17.
go back to reference Rosen ED, Scarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM: PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell. 1999, 4: 611-617. 10.1016/S1097-2765(00)80211-7.CrossRef Rosen ED, Scarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM: PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell. 1999, 4: 611-617. 10.1016/S1097-2765(00)80211-7.CrossRef
18.
go back to reference Pravenec M, Kazdova L, Landa V, Zidek V, Mlejnek P, Jansa P, Wang J, Qi N, Kurtz TW: Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J Biol Chem. 2003, 278: 45209-45215. 10.1074/jbc.M304869200.CrossRef Pravenec M, Kazdova L, Landa V, Zidek V, Mlejnek P, Jansa P, Wang J, Qi N, Kurtz TW: Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J Biol Chem. 2003, 278: 45209-45215. 10.1074/jbc.M304869200.CrossRef
19.
go back to reference Sethi JK, Hotamisligil GS: The role of TNFα in adipocyte metabolism. Cell Develop Biol. 1999, 10: 19-29. 10.1006/scdb.1998.0273.CrossRef Sethi JK, Hotamisligil GS: The role of TNFα in adipocyte metabolism. Cell Develop Biol. 1999, 10: 19-29. 10.1006/scdb.1998.0273.CrossRef
20.
go back to reference Guerre-Millo M: Adipose tissue and adipokines: for better or worse. Diabetes & Metabolism. 2004, 30: 13-19.CrossRef Guerre-Millo M: Adipose tissue and adipokines: for better or worse. Diabetes & Metabolism. 2004, 30: 13-19.CrossRef
21.
go back to reference Moon B, Kwan JJ, Duddy N, Sweeney G, Begum N: Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am Physi Endo Metabolism. 2003, 285: 106-115. Moon B, Kwan JJ, Duddy N, Sweeney G, Begum N: Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am Physi Endo Metabolism. 2003, 285: 106-115.
22.
go back to reference Morrison RF, Farmer SR: Role of PPARγ in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis. J Biol Chem. 1999, 274: 17088-17097. 10.1074/jbc.274.24.17088.CrossRef Morrison RF, Farmer SR: Role of PPARγ in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis. J Biol Chem. 1999, 274: 17088-17097. 10.1074/jbc.274.24.17088.CrossRef
23.
go back to reference Shao D, Lazar MA: Peroxisome proliferator activated receptor γ, CCAAT/enhancer-binding protein α, and cell cycle status regulate the commitment to adipocyte differentiation. J Biol Chem. 1997, 272: 21473-21478. 10.1074/jbc.272.34.21473.CrossRef Shao D, Lazar MA: Peroxisome proliferator activated receptor γ, CCAAT/enhancer-binding protein α, and cell cycle status regulate the commitment to adipocyte differentiation. J Biol Chem. 1997, 272: 21473-21478. 10.1074/jbc.272.34.21473.CrossRef
24.
go back to reference Spiegelman BM, Choy L, Hotamisligil G, Graves RA, Tontonoz P: Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J Biol Chem. 1993, 268: 6823-6826. Spiegelman BM, Choy L, Hotamisligil G, Graves RA, Tontonoz P: Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J Biol Chem. 1993, 268: 6823-6826.
25.
go back to reference Sartipy P, Loskutoff DJ: Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A. 2003, 100: 7265-7270. 10.1073/pnas.1133870100.CrossRef Sartipy P, Loskutoff DJ: Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A. 2003, 100: 7265-7270. 10.1073/pnas.1133870100.CrossRef
26.
go back to reference Esposito K, Pontillo A, Giugliano F, Giugliano G, Marfella R, Nicoletti G, Giuglianoet D: Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab. 2003, 88: 1055-1058. 10.1210/jc.2002-021437.CrossRef Esposito K, Pontillo A, Giugliano F, Giugliano G, Marfella R, Nicoletti G, Giuglianoet D: Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab. 2003, 88: 1055-1058. 10.1210/jc.2002-021437.CrossRef
27.
go back to reference Fu Y, Luo N, Klein RL, Garvey WT: Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res. 2005, 46: 1369-1379. 10.1194/jlr.M400373-JLR200.CrossRef Fu Y, Luo N, Klein RL, Garvey WT: Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res. 2005, 46: 1369-1379. 10.1194/jlr.M400373-JLR200.CrossRef
Metadata
Title
Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes
Authors
Yuchang Fu
Liehong Luo
Nanlan Luo
W Timothy Garvey
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2006
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/1743-7075-3-28

Other articles of this Issue 1/2006

Nutrition & Metabolism 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine